Charles River Laboratories International (MIL:1CRL) Interest Expense: €-91 Mil (TTM As of Mar. 2026)


MIL:1CRL Charles River Laboratories International Inc MIL:1CRL
69 GF Score
Price €143.90
GF Value €124.86
! 8 Warning Signs
View Full Analysis

What is Charles River Laboratories International Interest Expense?

Charles River Laboratories International MIL:1CRL 69 Interest Expense is €-91 Mil as of Mar. 2026. GuruFocus rates MIL:1CRL with a GF Score™ of 69/100 and a GF Value™ of €124.86. The stock has 8 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Charles River Laboratories International's interest expense for the three months ended in Mar. 2026 was € -23 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was €-91 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Charles River Laboratories International's Operating Income for the three months ended in Mar. 2026 was € 104 Mil. Charles River Laboratories International's Interest Expense for the three months ended in Mar. 2026 was € -23 Mil. Charles River Laboratories International's Interest Coverage for the quarter that ended in Mar. 2026 was 4.48. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Charles River Laboratories International  (MIL:1CRL) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Charles River Laboratories International's Interest Expense for the three months ended in Mar. 2026 was €-23 Mil. Its Operating Income for the three months ended in Mar. 2026 was €104 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was €2,644 Mil.

Charles River Laboratories International's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2026 )/Interest Expense (Q: Mar. 2026 )
=-1*103.711/-23.132
=4.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Charles River Laboratories International Interest Expense Historical Data

* Premium members only.

The historical data trend for Charles River Laboratories International's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Charles River Laboratories International Interest Expense Chart

Charles River Laboratories International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -65.41 -55.97 -125.36 -120.61 -91.40

Charles River Laboratories International Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -25.79 -25.98 -21.64 -20.30 -23.13
MIL:1CRL
69GF Score
Charles River Laboratories International Inc MIL:1CRL
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Charles River Laboratories International Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-91 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of €-91 Mil mean?
Charles River Laboratories International (MIL:1CRL) has a Interest Expense of €-91 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Charles River Laboratories International and its competitors.
Is Charles River Laboratories International's Interest Expense too high?
Charles River Laboratories International's current Interest Expense is €-91 Mil. Overall, Charles River Laboratories International has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Charles River Laboratories International's Interest Expense compare to RVTY and QGEN?
Charles River Laboratories International's Interest Expense of €-91 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Medical Diagnostics & Research company?
A good Interest Expense depends on the Medical Diagnostics & Research industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Charles River Laboratories International and its competitors. Charles River Laboratories International's current Interest Expense is €-91 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Charles River Laboratories International stock overvalued right now?
Charles River Laboratories International (MIL:1CRL) has a current Interest Expense of €-91 Mil. The stock's GF Value™ is €124.86, compared to a current price of €143.90 — trading 15.2% above its estimated fair value. The current Interest Expense is €-91 Mil. Charles River Laboratories International's overall GF Score™ is 69/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Charles River Laboratories International (MIL:1CRL), the current Interest Expense is €-91 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Charles River Laboratories International (MIL:1CRL) Overvalued in 2026?

Based on GuruFocus' analysis, Charles River Laboratories International stock appears to be overvalued. The current stock price of €143.90 is trading 15.2% above its estimated GF Value™ of €124.86.

Key valuation signals for MIL:1CRL:

  • Interest Expense: €-91 Mil
  • GF Value™: €124.86 vs. price of €143.90 (15.2% above fair value)
  • GF Score™: 69/100 with 8 warning signs

No single metric tells the full story. See the MIL:1CRL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Charles River Laboratories International Business Description

Other Exchanges CRL:USARV6:Germany
Address 251 Ballardvale Street, Wilmington, MA, USA, 01887
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
69GF Score

Get the complete analysis for MIL:1CRL

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€143.90
Price
€124.86
GF Value